Scinai Immunotherapeutics Announces $1.33M Registered Direct Offering Of 1,146,552 ADS At $1.16/ADS
Portfolio Pulse from Benzinga Newsdesk
Scinai Immunotherapeutics has announced a registered direct offering of 1,146,552 ADS at $1.16 per ADS, raising a total of $1.33 million.

September 15, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Scinai Immunotherapeutics' registered direct offering could potentially dilute the value of existing shares, potentially leading to a short-term decrease in stock price.
The announcement of a direct offering often leads to a short-term decrease in a company's stock price due to potential dilution of existing shares. However, the long-term impact can be positive if the funds raised are used effectively.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100